PDGFRA and infection: The efficient neutralization across different cell-types sets PDGFRα-Fc apart from many of the monoclonal antibodies that have been clinically tested because they are directed against components of the viral pentamer complex and inhibit infection of endothelial and epithelial cells more efficiently than infection of fibroblasts [32,35–37].